SciELO - Scientific Electronic Library Online

 
vol.39 número3Everolimus as a single agent in refractory or relapsed Hodgkin's lymphoma: the Brazilian Named Patient Program ExperienceHuman leukocyte antigen allele linkage disequilibrium and haplotype structure in volunteer bone marrow donors of Paraná State índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Revista Brasileira de Hematologia e Hemoterapia

versão impressa ISSN 1516-8484versão On-line ISSN 1806-0870

Rev. Bras. Hematol. Hemoter. vol.39 no.3 São Paulo jul./set. 2017

https://doi.org/10.1016/j.bjhh.2017.02.002 

Original articles

Ability of serum ferritin to diagnose iron deficiency anemia in an elderly cohort

Mansour Babaei1 

Sajedeh Shafiei1 

Ali Bijani1 

Behzad Heidari*  1 

Seyed Reza Hosseyni1 

Mohsen Vakili Sadeghi1 

1Babol University of Medical Sciences, Babol, Iran


Abstract

Background

Diagnosis and treatment of iron deficiency anemia in older subjects improves their quality of life. Serum ferritin as a marker of iron stores is an acute phase protein. In older subjects who usually have many concomitant chronic medical conditions, serum ferritin may increase in response to inflammatory processes irrespective of iron stores. This study was performed to determine the diagnostic properties of serum ferritin in the diagnosis of iron deficiency anemia in older subjects.

Methods

This case-control study included all the inhabitants of Amirkola town who participated in the Amirkola Health and Aging Project. Diagnosis of anemia was confirmed based on a hemoglobin level <13 g/dL in men and <12 g/dL in women and iron deficiency anemia by percent transferrin saturation <15%. A receiver operating characteristic curve was constructed to determine an optimal serum ferritin cutoff value to differentiate patients with and without iron deficiency anemia at the highest sensitivity and specificity.

Results

Eighty patients with iron deficiency anemia and 160 cases of anemia without iron deficiency (mean age: 72.9 ± 8 and 71.6 ± 7.6 years, respectively; p-value = 0.37) were analyzed. In iron deficiency anemia, the mean serum ferritin was significantly lower (p-value = 0.036) compared to patients without iron deficiency anemia. Serum ferritin with a cutoff level of 100 ng/mL differentiated patients with and without iron deficiency anemia with a sensitivity of 60% and specificity of 59% and area under the receiver operating characteristic curve of 0.615 ± 0.040 (95% confidence interval: 0.536-0.694; p-value = 0.004).

Conclusion

These findings indicate that in elderly subjects, iron deficiency anemia may develop with higher levels of serum ferritin. Hence, the conventional cutoff of serum ferritin for the diagnosis of iron deficiency anemia in young adults is not appropriate for the elderly population.

Keywords: Anemia; Diagnosis; Elderly; Ferritin; Iron deficiency

Introduction

Anemia affects one third of the world population with nearly half of the patients with anemia suffering from iron deficiency.1

In elderly people, even low levels of anemia affect the quality of life and increase the risk of mortality resulting in many medical conditions such as cardiovascular and cognitive disorders, osteopenia, muscle weakness, falls and fractures, and depression.2 Several factors such as inflammatory processes, chronic renal failure, and gastrointestinal and nutritional disorders are associated with anemia, in particular iron deficiency anemia (IDA). In the aged, the prevalence of anemia increases with age and ranges from 8% to 25%, nonetheless the causes of anemia, including the diagnosis of the iron deficiency state, remain undetermined in many patients.3-6 Currently, serum ferritin (SF) (ranging from 40 to 200 ng/mL) is a measure of iron stores in healthy adults. However, its diagnostic capability varies across different studies with regard to cutoff points.7-9

In elderly populations, changes in SF concentrations do not always correlate with variations in iron stores because ferritin is an acute phase protein and is affected by inflammatory processes irrespective of the iron store status.

Many chronic medical conditions in the general population such as obesity, metabolic syndrome, chronic obstructive pulmonary disease and diabetes are also prevalent in the elderly.10-19 These conditions are usually associated with inflammation.10,11,20,21 Coexistence of these comorbidities in aged people may be associated with elevated levels of acute phase proteins including SF. This situation results in the development of functional IDA (anemia of inflammation) which is associated with disproportionate release of iron from iron stores to compensate body demands with subsequent IDA. In these cases, in contrast to absolute IDA, SF does not reduce concomitantly with iron stores.

This issue creates difficulties in the diagnostic capability of the ferritin test to diagnose IDA. Thus, the classic cutoff value of SF as applied to young adults may be inappropriate for the diagnosis of IDA in the elderly. These observations warrant further investigations to determine a SF level with more reliable diagnostic properties. A systematic review of 55 studies found variations in SF test results across populations with and without inflammatory processes, liver disease or neoplastic diseases. Although ferritin is not an excellent measure of iron stores, it is a practical and widely used method to assess iron stores.22

For these reasons, the present study was designed to determine an optimal SF level to differentiate elderly patients with and without IDA with greater sensitivity and specificity. The secondary purpose of this study was to determine the diagnostic properties of different levels of SF in the diagnosis of IDA in a cohort of the elderly subjects aged 60 years and older.

Methods

The patients of this case-control study were recruited among the participants of the Amirkola Health and Aging Project (AHAP). This project was carried out in Amirkola, Babol, a town located near the Caspian Sea, northern Iran. The project was funded by the Vice-Chancellery of Research and Technology, Babol University of Medical Sciences for the investigation of geriatric medical problems such as falling, bone fragility and fractures, cognitive impairment and dementia, poor mobility and functional dependence. The baseline stage of this project was carried out in 2011 and 2012. All inhabitants aged 60 years and over were invited to participate in this study with 72.3% of the invited subjects participating.12 All patients with anemia, defined as a hemoglobin level lower than 13 g/dL in men and 12 g/dL in women, were included in the study. Participants with a history of transfusion within six months prior to the start of this study, those taking iron supplements, and patients with chronic renal failure and on maintenance hemodialysis were excluded.

All patients gave informed consent and the proposal of this study was approved by the Ethics Committee of the Babol University of Medical Sciences, Babol, Iran.

Data were collected regarding serum iron, percent of transferrin saturation and SF and the prevalence of coexistent chronic medical conditions was recorded.

Data regarding chronic diseases were provided by clinical examination, interviews and review of medical records. The diagnosis of IDA was confirmed based on transferrin saturation levels of less than 15%. Details of patient selection, data collection and laboratory test results have been described elsewhere.12

In the statistical analysis, the participants of this study were classified as patients with and without IDA. Eighty patients with IDA were compared with 160 patients with anemia without iron deficiency. The two groups were compared regarding SF and percent of transferrin saturation.

The diagnostic ability of SF was determined by receiver operating characteristic (ROC) curve analysis. The optimal cutoff levels that differentiated patients with and without IDA at the highest sensitivity and specificity rates were determined using Youden's index calculated by sensitivity + specificity - 1. The accuracy of test was assessed based on area under the ROC curve (AUC). The distribution of all variables was tested for normality using the Kolmogorov-Smirnov test. Parametric and non-parametric tests were used for analyses of variables with and without normal distribution, respectively. The Statistical Package for the Social Sciences (SPSS) software version 18 was employed for analysis.

Results

The Amirkola Cohort Profile included all inhabitants living in the 34 districts of Amirkola town, 2234 of whom were aged 60 years or older when this study began (1158 men and 1076 women). Thirty-five out of 2234 participants were excluded and 114 women and 126 men out of 1994 participants (12.03%) who had anemia were studied. Eighty patients with IDA, with a mean age of 72.9 ± 8 and 160 patients without IDA with a mean age of 71.6 ± 7.6 years old (p-value = 0.37) were analyzed (Table 1).

Table 1 Comparison of iron parameters in elderly subjects aged 60 years and older with and without iron deficiency anemia. 

Variables IDA present
n = 80
IDA absenta
n = 160
p-Valuec
Age (Mean ± SD) - years 72.9 ± 8 71.6 ± 7.6 0.37
Hemoglobin level - g/dL 9.7 ± 1.3 10.1 ± 1.2 0.018
Serum iron - µg/dL 35.8 ± 8.3 95.3 ± 26.4 0.001
Transferrin - µg/dL 333.1 ± 26.7 269 ± 28.8 0.001
Transferrin saturation level - mean, % 10.85 ± 2.2 31.1 ± 8.2 0.001
Serum ferritin - ng/mL 148.5 ± 147.7 188.4 ± 134 0.036

IDA: iron deficiency anemia.

aConfirmed by transferrin saturation <15%.bNon-IDA anemia.

cStudent's t-test was used for comparison.

Coexistent common chronic medical diseases such as, hypertension, urinary incompetence, diabetes, chronic lung disease, hypothyroidism and congestive heart failure were found in 41.6%, 24.5%, 34.1%, 7.5%, 4.1% and 2.5% of the total patients with anemia, respectively. Prevalence of comorbidities in patients with and without IDA are presented in Table 2. The prevalence of diabetes, chronic lung disease and hypothyroidism was significantly higher in patients with IDA but the prevalences of incontinency and hypertension were lower compared to those without IDA.

Table 2 Prevalence of chronic medical conditions in patients with and without iron deficiency anemia in elderly subjects aged 60 years and more. 

Chronic medical conditions Iron deficiency anemia N = 80
n (%)
Anemia without iron deficiency
N = 160
n (%)
p-Value
Chronic lung disease 13 (16.2) 5 (8) 0.001
Diabetes 48 (60) 34 (21.25) 0.001
Urinary incompetence 8 (5) 51 (63.7) 0.001
Hypertension 57 (35.6) 43 (53.7) 0.001
Congestive heart failure 2 (2.5) 4 (2.5) 0.64
Hypothyroidism 6 (7.5) 4 (2.5) 0.013

In iron deficient patients, serum iron concentration was significantly lower, serum transferrin was significantly higher, and both transferrin saturation and SF were significantly lower compared with patients without iron deficiency (Table 1).

SF at cutoff level of 100 ng/mL differentiated patients with and without IDA with a sensitivity of 60% and specificity of 59% with the area under the ROC curve of 0.615 ± 0.040 [95% Confidence interval (95% CI): 0.536-0.694; p-value = 0.004].

This cutoff level yielded positive and negative predictive values of 45% and 74%, respectively. Further analyses were performed to determine the diagnostic performance for other levels of SF (Table 3). SF levels lower than 18 ng/mL yielded the highest likelihood ratio of 3.71 (95% CI: 1.5-8.4), sensitivity of 16% and specificity of 96% for the diagnosis of IDA (Table 3). Serum cutoff levels of 45 ng/mL and 60 ng/mL yielded positive likelihood ratios of 2.54 (95% CI: 1.4-4.4) and 2.33 (95% CI: 1.4-3.73), respectively. In patients with SF levels less than 100 ng/mL, the likelihood of IDA decreased to 1.61 (95% CI: 1.18-2.2) with negative predictive value of 72% and likelihood negative ratio of 0.76.

Table 3 Diagnostic properties for different cutoff levels of serum ferritin in diagnosis of iron deficiency anemia in elderly patients aged >60 years old. 

18 ng/mL 45 ng/mL 60 ng/mL 100 ng/mL
Sensitivity (95% CI) 16 (8-24) 29 (19-30) 35 (25-45) 51 (40-62)
Specificity (95% CI) 96 (92-99) 89 (84-94) 85 (79-91) 68 (61-75)
PPV (95% CI) 66 (44-86) 56 (41-71) 53 (40-67) 44.3 (34-55)
NPV (95% CI) 69 (63-70) 71 (65-78) 72 (66-79) 73.4 (67-81)
LR+ (95% CI) 4 (1.5-8.4) 2.64 (1.4-4.4) 2.3 (1.4.3.75) 1.6 (1.18-2.20)
LR- (95% CI) 0.87 (0.79-0.97) 0.8 (0.69-0.93) 0.76 (0.64-0.91) 0.72 (0.56-0.92)

95% CI: 95% confidence interval; PPV: positive predictive value; NPV: negative predictive value; LR+: likelihood ratio positive; LR-: likelihood ratio negative.

Discussion

The results of this study indicate that, in elderly subjects, SF tests have a different diagnostic ability according to the cutoff levels. In the present study, the optimal SF with a cutoff point of 100 ng/mL yielded the highest sensitivity and specificity for the diagnosis of IDA in subjects aged 60 years and older. Based on this study, SF of less than 100 ng/mL identified 51% of patients who had transferrin saturation <15%, whereas SF >100 ng/mL identified 74% of subjects without IDA indicating a higher negative predictive value compared to the positive predictive value. This suggests that in elderly subjects SF levels >100 ng/mL compared with <100 ng/mL yield greater ability to exclude rather than confirm IDA.

This study found different diagnostic properties across various SF levels. Compared to the cutoff level of 100 ng/mL, cutoffs of 18 ng/mL, 45 ng/mL and 60 ng/mL yielded greater positive predictive values as well as positive likelihood ratios but lower sensitivity for the diagnosis of IDA (Table 3).

O ff levels of 45 and 60 ng/mL yielded comparable diagnostic properties, levels ≤18 ng/mL compared with other cutoff points exhibited higher specificity and likelihood ratio but lower sensitivity.

Overall, by increasing SF cutoff levels, the sensitivity and the negative predictive value of this test in the diagnosis of IDA increases at the expense of decreasing specificity and the positive predictive value.

In the present study, the mean SF in patients with IDA was higher than 100 ng/mL, whereas in a study of apparently healthy 80-year-old Danish men and women, the median SF value was 100 ng/mL in men and 78 ng/mL in women. In 9% of these subjects, the SF levels were >300 ng/mL.23 In a study of 73 patients with anemia and chronic diseases by Coenen et al., SF concentrations of less than 70 ng/mL were always indicative of IDA.24 In patients with inflammatory disease such as rheumatoid arthritis, iron deficiency anemia may develop at higher levels of SF and so the cutoff point is expected to be higher.25 The results of a systematic review suggest that further investigations are needed on the diagnosis of IDA in conditions with SF concentrations lower than 100 ng/mL.26

The results of another study of anemic veterans with a wide variety of general medical comorbidities were partly similar to this study. The study found a sensitivity of 64.9% with SF ≤100 ng/mL and a specificity of 96.1% to detect patients with IDA.27

The cutoff points for SF in patients with IDA in previous studies vary from 12 to 100 ng/mL.7,23,24,27 In a randomly selected sample of 38-year-old women, SF <16 ng/mL was the best cutoff level to differentiate patients with and without iron deficiency with a sensitivity of 75% and specificity of 98%; the iron stores began to disappear at SF levels from 25 to 40 ng/mL.7 However, compared to the current study the age of patients was lower.

In another study of elderly patients, SF measurement was the best diagnostic test to discriminate patients with and without IDA. In this study, the likelihood of diagnosis of IDA in cases with SF from 18 to 45 ng/mL was 3.12 and in those with less than 18 ng/mL, it was 41.47, with a negative predictive value of 72%.22

This study indicates that, in elderly people, SF has less diagnostic ability compared to percent of transferrin saturation. In a study of 49 consecutive subjects aged 80 years or more with IDA as confirmed by bone marrow aspiration, correct diagnosis by SF, serum iron and percent of transferrin saturation was possible in only 16.3%.28

Variations in the diagnostic ability of SF to diagnose IDA across various studies may be attributed to factors such as the diagnostic criteria applied for IDA, characteristics of the study patients, and the prevalence of comorbidities in the study patients.6,7,22,24-32 The presence of comorbidities in the study population, particularly in older subjects, is associated with elevated levels of acute phase proteins including ferritin and thus may affect the cutoff level and change the results.

In a study of patients in the general practice aged 65 years and older, 23% suffered from at least one chronic disease with 15% suffering from more than one chronic disease such osteoarthritis, diabetes, chronic obstructive pulmonary disease, coronary artery disease, hypertension and diabetes.18 In another study, 82% of aged Medicare beneficiaries had one or more chronic conditions and 65% had multiple chronic conditions.17 About 82% of the participants aged 65-84 years of the 2003 National Sleep Foundation study reported one or more of 11 medical conditions and nearly 25% of respondents had four or more conditions such as obesity, arthritis, diabetes, lung disease, stroke and osteoporosis.19 In the present study hypertension, urinary incontinency, diabetes and chronic lung disease were found in significant proportions of patients in both groups. Most chronic medical conditions particularly diabetes, urinary incontinency and chronic lung disease are associated with inflammatory processes.10,11,13-16,20,21 The prevalence of both general and abdominal obesity increases with aging.13,14 Obesity is associated with inflammation and there is a positive correlation between the body mass index and SF.33

The limitations of this study should be considered. One major limitation is the lack of bone marrow aspiration for definitive diagnosis of iron deficiency anemia. Although absence of iron in the bone marrow is considered the gold standard diagnostic test for diagnosis of IDA, the lack of iron stores in the bone marrow aspirate is not necessarily predictive of IDA.34 In a retrospective study of 12 patients with depleted iron stores, iron deficiency was the cause of anemia only in 50% of the patients.34 However, Klantar-Zadeh et al. reported high sensitivity and specificity of the percent of transferrin saturation test in the diagnosis of IDA in chronic renal disease with inflammatory conditions.35 Another limitation is related to lack of data concerning the assessment of serum C-reactive protein and other measures of inflammation to show the existence of inflammatory processes. However, the high prevalence of diabetes, chronic lung disease and urinary incontinence even in the control group indicates that there were chronic comorbidities in the elderly people, and consequently inflammatory processes are common.

The strength of this study is related to the study sample which included all participants of the Almirkola Cohort Study that enrolled all the inhabitants of Amirkola, a small town in northern Iran. Another strength is related to the homogeneity of the study population in respect to demographic features, lifestyle and ethnicity.

The clinical significance of these findings is related to the incapability of the SF test as a measure to identify IDA in elderly people. These findings suggest that SF levels in many elderly subjects with IDA may be normal or higher than normal, and thus SF using conventional cutoff levels is not a reliable measure in the diagnosis of absolute IDA.

Conclusion

In conclusion, the results of this study indicate that SF is not an appropriate test for the diagnosis of IDA in the elderly subjects aged 60 years and older. Based on these findings the SF cutoff level of 100 ng/mL can predict half of the patients with absolute IDA, whereas SF >100 yields a 74% negative predictive value, indicating that in elderly people higher levels of SF are better to exclude IDA rather than low levels of SF to confirm IDA. This context requires further studies.

Acknowledgement

We thank the Clinical Research Development Unit Of Rouhani Hospital for assistance in manuscript submission and references arrangement.

References

1 von Haehling S, Jankowska EA, van Veldhuisen DJ, Ponikowski P, Anker SD. Iron deficiency and cardiovascular disease. Nat Rev Cardiol. 2015;12(11):659-69. [ Links ]

2 Busti F, Campostrini N, Martinelli N, Girelli D. Iron deficiency in the elderly population, revisited in the hepcidin era. Front Pharmacol. 2014;23(5):83. [ Links ]

3 Andrès E, Erraj K, Federici L, Vogel T, Kaltenbach G. Anemia in elderly patients: new insight into an old disorder. Geriatr Gerontol Int. 2013;13(3):519-27. [ Links ]

4 Le Petitcorps H, Monti A, Pautas E. Iron deficiency in elderly patients: use of biomarkers. Annales Biol Clin. 2015;73(6):639-42. [ Links ]

5 Eisenstaedt R, Penninx BW, Woodman RC. Anemia in the elderly: current understanding and emerging concepts. Blood Rev. 2006;20(4):213-26. [ Links ]

6 Chaves PH, Semba RD, Leng SX, Woodman RC, Ferrucci L, Guralnik JM, et al. Impact of anemia and cardiovascular disease on frailty status of community-dwelling older women: the Women's Health and Aging Studies I and II. J Gerontol A Biol Sci Med Sci. 2005;60(6):729-35. [ Links ]

7 Hallberg L, Bengtsson C, Lapidus L, Lindstedt G, Lundberg PA, Hulten L. Screening for iron deficiency: an analysis based on bone-marrow examinations and SF determinations in a population sample of women. Br J Haematol. 1993;85(4):787-98. [ Links ]

8 Mast AE, Blinder MA, Gronowski AM, Chumley C, Scott MG. Clinical utility of the soluble transferrin receptor and comparison with SF in several populations. Clin Chem. 1998;44(1):45-51. [ Links ]

9 Ong KH, Tan HL, Lai HC, Kuperan P. Accuracy of various iron parameters in the prediction of iron deficiency in an acute care hospital. Ann Acad Med Singapore. 2005;34(7):437-40. [ Links ]

10 Firouzjahi A, Monadi M, Karimpoor F, Heidari B, Dankoob Y, Hajian-Tilaki K, et al. Serum C-reactive protein level and distribution in chronic obstructive pulmonary disease versus healthy controls: a case-control study from Iran. Inflammation. 2013;36(5):1122-8. [ Links ]

11 Heidari B. C-reactive protein and other markers of inflammation in hemodialysis patients. Caspian J Intern Med. 2013;4(1):611-6. [ Links ]

12 Hosseini SR, Cumming RG, Kheirkhah F, Nooreddini H, Baiani M, Mikaniki E, et al. Cohort profile: the Amirkola Health and Ageing Project (AHAP). Int J Epidemiol. 2014;43(5):1393-400. [ Links ]

13 Hajian-Tilaki K, Heidari B, Firouzjahi A, Bagherzadeh M, Hajian-Tilaki A, Halalkhor S. Prevalence of metabolic syndrome and the association with socio-demographic characteristics and physical activity in urban population of Iranian adults: a population-based study. Diabetes Metab Syndr. 2014;8(3):170-6. [ Links ]

14 Hajian-Tilaki KO, Heidari B. Prevalence of obesity, central obesity and the associated factors in urban population aged 20-70 years, in the north of Iran: a population-based study and regression approach. Obes Rev. 2007;8(1):3-10. [ Links ]

15 Hajian-Tilaki K, Heidari B. Prevalences of overweight and obesity and their association with physical activity pattern among Iranian adolescents aged 12-17 years. Public Health Nutr. 2012;15(12):2246-52. [ Links ]

16 Hajian-Tilaki K, Heidari B. Childhood obesity, overweight, socio-demographic and life style determinants among preschool children in Babol, Northern Iran. Iran J Public Health. 2013;42(11):1283-91. [ Links ]

17 Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162(20):2269-76. [ Links ]

18 Schellevis FG, van der Velden J, van de Lisdonk E, van Eijk JT, van Weel C. Comorbidity of chronic diseases in general practice. J Clin Epidemiol. 1993;46(5):469-73. [ Links ]

19 Foley D, Ancoli-Israel S, Britz P, Walsh J. Sleep disturbances and chronic disease in older adults: results of the 2003 National Sleep Foundation Sleep in America Survey. J Psychosom Res. 2004;56(5):497-502. [ Links ]

20 Heidari B, Heidari P, Tayebi ME. The value of changes in CRP and ESR for predicting treatment response in rheumatoid arthritis. APLAR J Rheumatol. 2007;10(1):23-8. [ Links ]

21 Heidari B. The importance of C-reactive protein and other inflammatory markers in patients with chronic obstructive pulmonary disease. Caspian J Intern Med. 2012;3(2):428-35. [ Links ]

22 Guyatt GH, Patterson C, Ali M, Singer J, Levine M, Turpie I, et al. Diagnosis of iron-deficiency anemia in the elderly. Am J Med. 1990;88(3):205-9. [ Links ]

23 Milman N, Pedersen AN, Ovesen L, Schroll M. Iron status in 358 apparently healthy 80-year-old Danish men and women: relation to food composition and dietary and supplemental iron intake. Ann Hematol. 2004;83(7):423-9. [ Links ]

24 Coenen JL, van Dieijen-Visser MP, van Pelt J, van Deursen CT, Fickers MM, van Wersch JW, et al. Measurements of SF used to predict concentrations of iron in bone marrow in anemia of chronic disease. Clin Chem. 1991;37(4):560-3. [ Links ]

25 Hansen TM, Hansen NE, Birgens HS, Holund B, Lorenzen I. SF and the assessment of iron deficiency in rheumatoid arthritis. Scand J Rheumatol. 1983;12(4):353-9. [ Links ]

26 Peyrin-Biroulet L, Williet N, Cacoub P. Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review. Am J Clin Nutr. 2015;102(6):1585-94. [ Links ]

27 Kis A, Carnes M. Detecting iron deficiency in anemic patients with concomitant medical problems. J Gen Intern Med. 1998;13(7):455-61. [ Links ]

28 Rimon E, Levy S, Sapir A, Gelzer G, Peled R, Ergas D, et al. Diagnosis of iron deficiency anemia in the elderly by transferrin receptor-ferritin index. Arch Intern Med. 2002;162(4):445-9. [ Links ]

29 Takasaki M, Tsurumi N, Konjiki O, Sakurai H, Kanou H, Yanagawa K, et al. Causes, diagnosis, and treatment of anemia in the elderly. Nihon Ronen Igakkai Zasshi. 1997;34(3):171-9. [ Links ]

30 Choi CW, Cho WR, Park KH, Choi IK, Seo JH, Kim BS, et al. The cutoff value of SF for the diagnosis of iron deficiency in community-residing older persons. Ann Hematol. 2005;84(6):358-61. [ Links ]

31 Contreras-Manzano A, Cruz Vde L, Villalpando S, Rebollar R, Shamah-Levy T. Anemia and iron deficiency in Mexican elderly population: results from the Ensanut 2012. Salud Publica Mex. 2015;57(5):394-402. [ Links ]

32 Heidari B, Fazli MR, Misaeid MA, Heidari P, Hakimi N, Zeraati AA. A linear relationship between serum high-sensitive C-reactive protein and hemoglobin in hemodialysis patients. Clin Exp Nephrol. 2015;19(4):725-31. [ Links ]

33 Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006;17(1):4-12. [ Links ]

34 Ganti AK, Moazzam N, Laroia S, Tendulkar K, Potti A, Mehdi SA. Predictive value of absent bone marrow iron stores in the clinical diagnosis of iron deficiency anemia. In vivo (Athens, Greece). 2003;17(5):389-92. [ Links ]

35 Kalantar-Zadeh K, Hoffken B, Wunsch H, Fink H, Kleiner M, Luft FC. Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era. Am J Kidney Dis. 1995;26(2):292-9. [ Links ]

Received: October 2, 2016; Accepted: February 9, 2017

*Corresponding author at: Department of Medicine, Division of Rheumatology, Rouhani Hospital, Clinical Research Development Unit of Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran. adreess.bheidari6@gmail.com (B. Heidari).

Conflict of interest

The authors declare no conflicts of interest.

Creative Commons License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivative License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium provided the original work is properly cited and the work is not changed in any way.